Skip to content
PubMed This is a summary of 16 peer-reviewed journal articles Updated
Behçet's disease

Is Behçet's Disease Hereditary? HLA-B51 Gene Explained

At a Glance

Behçet's disease is not directly hereditary. Even if you test positive for the HLA-B51 susceptibility gene, the risk of passing the disease to your children is less than 5%. Most people who carry this gene will go their entire lives without ever developing Behçet's disease.

If you have tested positive for the HLA-B51 gene, the short answer is no: your children will not definitely get Behçet’s disease. While the HLA-B51 gene is linked to an increased risk of developing Behçet’s, it is not a direct genetic inheritance like cystic fibrosis or sickle cell anemia [1][2]. In fact, many people who carry the HLA-B51 gene never develop Behçet’s disease at all [3][4].

When researchers look at families with Behçet’s, the overall risk of a parent passing the disease to their child is actually quite low—typically estimated at less than 2% to 5% globally, though it can be slightly higher for families in Middle Eastern regions where the disease is most common [5].

What is the HLA-B51 Gene?

To understand your risk, it helps to know what HLA-B51 actually is. The human leukocyte antigen (HLA) system is a group of genes that help your immune system distinguish your own body’s proteins from proteins made by foreign invaders (like viruses and bacteria).

Testing positive for the HLA-B51 gene means you carry a specific version (an “allele”) of one of these immune system genes. It is considered a susceptibility marker, meaning it makes someone more susceptible to developing Behçet’s disease [6][7]. This gene variant is particularly common in populations along the historic “Silk Road” — stretching from the Middle East through Central and East Asia — which matches where Behçet’s disease is most frequently diagnosed [8][9].

However, carrying a susceptibility marker is very different from carrying a disease-causing mutation.

Why Having the Gene Doesn’t Guarantee the Disease

Behçet’s disease is a multifactorial and polygenic condition [2][10]. This means it requires a complex “perfect storm” of many different factors to develop:

  • Low Penetrance: In genetics, “penetrance” refers to how often a gene actually causes the trait it’s linked to. The HLA-B51 gene has very low penetrance for Behçet’s disease [3][4]. The vast majority of people with this gene will go their entire lives without ever developing Behçet’s.
  • Other Genes: HLA-B51 does not work alone. Research shows that it interacts with other genes—such as ERAP1 and IL23R, which help manage the body’s inflammation levels—to influence disease risk [11][1][12]. Unless a person inherits a very specific combination of these genes, the risk remains minimal.
  • Environmental Triggers: Even with the “right” genetic combination, Behçet’s disease seems to require an environmental trigger to activate the immune system. Researchers believe factors like the microbiome (the bacteria naturally living in your mouth and gut) or certain childhood infections may play a role [13][4]. Currently, there is no specific diet or lifestyle change proven to prevent these triggers, so parents should not feel pressured to heavily restrict their children’s habits.

The Real Risk to Your Children

Because you have the HLA-B51 gene, there is a chance you will pass the gene itself to your children. But even if they inherit the gene, the absolute risk that they will actually develop Behçet’s disease remains less than 5% [5]. In fact, studies show that familial risk is actually slightly higher between siblings than it is from parent to child [14].

There is no guarantee your children will get it, and medical guidelines do not recommend proactively testing asymptomatic children for the HLA-B51 gene.

Moving Forward: Timelines and Symptoms

Instead of worrying about genetic destiny, the best approach is awareness. Keep in mind that Behçet’s disease typically develops in a person’s 20s or 30s [15]. It is extremely rare for classic Behçet’s to develop in early childhood.

Routine, simple canker sores are incredibly common in healthy children and are rarely a sign of Behçet’s. However, if severe, unusual, and persistent Behçet’s-like symptoms do appear in very early childhood, doctors may look for ultra-rare “monogenic” conditions (like HA20) that mimic Behçet’s but have different inheritance patterns [1][16].

If symptoms do arise down the road, recurrent mouth ulcers are almost always the first symptom to appear [5][10]. This is usually followed later by genital sores, skin lesions, or eye inflammation (uveitis) [15][10]. Having your health history on file helps doctors make faster, more accurate diagnoses if symptoms ever do arise in your child’s adulthood.

Common questions in this guide

If I have Behçet's disease, will my children get it?
The risk of passing Behçet's disease to your children is very low, typically less than 5%. While they may inherit genetic markers like HLA-B51, this is not a direct genetic inheritance and does not guarantee they will develop the condition.
What does testing positive for the HLA-B51 gene mean?
Testing positive for the HLA-B51 gene means you carry a susceptibility marker for Behçet's disease. However, the gene has very low penetrance, meaning the vast majority of people who have it will never actually develop the disease.
Should I test my child for the HLA-B51 gene?
Medical guidelines do not recommend proactively testing healthy, asymptomatic children for the HLA-B51 gene. Having the gene does not mean they will get Behçet's, and the disease rarely develops in early childhood anyway.
What triggers Behçet's disease if you have the gene?
Researchers believe Behçet's disease requires an environmental trigger to activate the immune system, even if you have the genetic markers. These triggers may include certain childhood infections or factors related to the natural bacteria in your mouth and gut.
What symptoms of Behçet's disease should I watch for in my family?
The most common early symptom is severe, recurrent mouth ulcers or canker sores. Over time, other symptoms may appear, such as genital sores, skin lesions, or eye inflammation (uveitis), typically developing in a person's 20s or 30s.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Given my HLA-B51 status, what specific symptoms should I watch for in my children as they grow, keeping in mind the typical age of onset?
  2. 2.How can I make a note of my Behçet's diagnosis or HLA-B51 status in my child's medical chart without triggering unnecessary diagnostic testing?
  3. 3.If my child gets typical childhood canker sores, at what point of severity or frequency should I bring them to your attention?
  4. 4.Are there other genetic markers or risk factors for Behçet's disease that are relevant to my specific family history or ethnic background?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (16)
  1. 1

    Lesional activation of Tc 17 cells in Behçet disease and psoriasis supports HLA class I-mediated autoimmune responses.

    Vural S, Kerl K, Ertop Doğan P, et al.

    The British journal of dermatology 2021; (185(6)):1209-1220 doi:10.1111/bjd.20643.

    PMID: 34254298
  2. 2

    Age-related differences in the clinical phenotypes of Behçet's disease: The experience of two referral centres.

    Tekgöz N, Tekgöz E, Çolak S, et al.

    Modern rheumatology 2023; (34(1)):194-200 doi:10.1093/mr/road012.

    PMID: 36688579
  3. 3

    Behçet's syndrome: recent advances to aid diagnosis.

    Akbaba TH, Ekici M, Çolpak Aİ, et al.

    Clinical and experimental medicine 2023; (23(8)):4079-4090 doi:10.1007/s10238-023-01226-7.

    PMID: 37897656
  4. 4

    Behçet's Disease, Pathogenesis, Clinical Features, and Treatment Approaches: A Comprehensive Review.

    Lavalle S, Caruso S, Foti R, et al.

    Medicina (Kaunas, Lithuania) 2024; (60(4)) doi:10.3390/medicina60040562.

    PMID: 38674208
  5. 5

    Clinical and Demographical Characteristics of Familial Behçet's Disease (Southeast Marmara Region).

    Ceylan Kalın Z, Sarıcaoğlu H, Yazici S, et al.

    Dermatology (Basel, Switzerland) 2019; (235(5)):407-412 doi:10.1159/000500820.

    PMID: 31288224
  6. 6

    Genetic Analysis with the Immunochip Platform in Behçet Disease. Identification of Residues Associated in the HLA Class I Region and New Susceptibility Loci.

    Ortiz-Fernández L, Carmona FD, Montes-Cano MA, et al.

    PloS one 2016; (11(8)):e0161305 doi:10.1371/journal.pone.0161305.

    PMID: 27548383
  7. 7

    When it looks like Behçet's syndrome but is something else: differential diagnosis of Behçet's syndrome: a two-centre retrospective analysis.

    Lötscher F, Kerstens F, Krusche M, et al.

    Rheumatology (Oxford, England) 2023; (62(11)):3654-3661 doi:10.1093/rheumatology/kead101.

    PMID: 36864623
  8. 8

    HLA-B51 Carriers are Susceptible to Ocular Symptoms of Behçet Disease and the Association between the Two Becomes Stronger towards the East along the Silk Road: A Literature Survey.

    Horie Y, Meguro A, Ohta T, et al.

    Ocular immunology and inflammation 2017; (25(1)):37-40 doi:10.3109/09273948.2015.1136422.

    PMID: 26954704
  9. 9

    Global Meta-Analysis on the Association between Behcet Syndrome and Polymorphisms from the HLA Class I (A, B, and C) and Class II (DRB1, DQB1, and DPB1) Genes.

    Capittini C, Rebuffi C, Lenti MV, et al.

    Disease markers 2021; (2021()):9348697 doi:10.1155/2021/9348697.

    PMID: 34938376
  10. 10

    Clinical Features and Phenotypic Similarities of Patients with Familial Behçet's Disease.

    Abacar K, Boncukcuoğlu AE, Deniz R, et al.

    European journal of rheumatology 2025; (12(2)):1-5 doi:10.5152/eurjrheum.2025.24116.

    PMID: 40873392
  11. 11

    A single endoplasmic reticulum aminopeptidase-1 protein allotype is a strong risk factor for Behçet's disease in HLA-B*51 carriers.

    Takeuchi M, Ombrello MJ, Kirino Y, et al.

    Annals of the rheumatic diseases 2016; (75(12)):2208-2211 doi:10.1136/annrheumdis-2015-209059.

    PMID: 27217550
  12. 12

    [The etiology, diagnosis, and treatment of neurological complications in Behçet disease and its related disorder Sweet disease].

    Hisanaga K

    Rinsho shinkeigaku = Clinical neurology 2019; (59(1)):1-12 doi:10.5692/clinicalneurol.cn-001238.

    PMID: 30606996
  13. 13

    Functional and taxonomic dysbiosis of the supragingival plaque metagenome in Behçet's disease.

    Sapthanakorn T, Choopong P, Sermsripong W, et al.

    Journal of oral microbiology 2025; (17(1)):2552165 doi:10.1080/20002297.2025.2552165.

    PMID: 40904740
  14. 14

    Familial risk of Behçet's disease among first-degree relatives: a population-based aggregation study in Korea.

    Ahn HS, Kim HJ, Kazmi SZ, et al.

    Rheumatology (Oxford, England) 2021; (60(6)):2697-2705 doi:10.1093/rheumatology/keaa682.

    PMID: 33241295
  15. 15

    HLA-B51 Impact on Clinical Symptoms in Behcet's Disease.

    Pamukcu M, Duran TI, Demirag MD

    Journal of the College of Physicians and Surgeons--Pakistan : JCPSP 2022; (32(7)):904-908 doi:10.29271/jcpsp.2022.07.904.

    PMID: 35795941
  16. 16

    Monogenic mimics of Behçet's disease in the young.

    Papadopoulou C, Omoyinmi E, Standing A, et al.

    Rheumatology (Oxford, England) 2019; (58(7)):1227-1238 doi:10.1093/rheumatology/key445.

    PMID: 30715505

This page provides educational information about the genetics of Behçet's disease and the HLA-B51 gene. It does not replace professional medical advice, and you should always consult your healthcare provider regarding specific family health risks.

Get notified when new evidence is published on Behçet disease.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.